TCM Formula

DRUG4 trials

Sponsors

China Medical University Hospital, Peking University Cancer Hospital & Institute, Tri-Service General Hospital

Conditions

Advanced Lung AdenocarcinomaAgingCancer-related Problem/ConditionDry EyeDry Eye DiseaseDry Eye SyndromesMuscle Atrophy or WeaknessOsteoporosis

Phase 2

Effect of Traditional Chinese Medicine on Basic Tear Secretion and Tear Cytokines in Patients With Dry Eye Disease

China Medical University HospitalDry Eye, Dry Eye Disease, Dry Eye Syndromes

Start: 2021-03-16End: 2022-05-31Target: 60Updated: 2021-12-06

RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy

Active, not recruitingNCT05229029

Peking University Cancer Hospital & InstituteCancer-related Problem/Condition

Start: 2020-04-02End: 2024-06-30Target: 196Updated: 2024-01-19

TCM Formula vs. HMB in Pre-Frail Elders: Muscle Strength and Bone Status

RecruitingNCT07597850

Tri-Service General HospitalAging, Muscle Atrophy or Weakness, Osteoporosis +2

Start: 2026-04-02End: 2026-12-31Target: 90Updated: 2026-05-19

Phase 3

Prophylactic TCM for Mitigation of EGFR-TKI Related Dermatological Adverse Effect

CompletedNCT05204758

China Medical University HospitalAdvanced Lung Adenocarcinoma

Start: 2016-05-12End: 2021-02-28Updated: 2022-01-24

Related Papers

Efficacy of treatment with traditional Chinese medicine (Renshen Yangrong Tang granules) for cancer-related fatigue in patients with platinum-based chemotherapy: A randomized, double- blinded, placebo-controlled, multicenter trial.

Journal of Clinical Oncology2025-05-28

Efficacy of Prophylactic Traditional Chinese Medicine on Skin Toxicity of Afatinib in <i>EGFR</i> Mutation-Positive Advanced Lung Adenocarcinoma: A Single-Center, Prospective, Double-Blinded, Randomized-Controlled Pilot Trial

Integrative Cancer Therapies2022-01-015 citations